I also think it is a sign of the time we are in at the moment. People don’t have money to spend on taking a punt on stocks that they don’t understand, like during COVID when people were cashed up.
But just to surmise, what would be the reason for the FDA to knock back their approval? Last time round, the FDA did not ask for more trial data. They simply wanted to know more about the crucible of Technegas. With the amount of time it took the company to prepare this resubmission, it’s shows they have been detailed in their response.
Anybody got any more ideas of a possible CRL?
Ann: Application for quotation of securities - CYC, page-8
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.050(3.21%) |
Mkt cap ! $176.4M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.63 | $1.58 | $37.20K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4837 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 6559 | 2 |
View Market Depth
| Last trade - 11.12am 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.60 |
Change
0.050 ( 1.27 %) |
||||
| Open | High | Low | Volume | ||
| $1.62 | $1.63 | $1.58 | 2601 | ||
| Last updated 13.09pm 07/06/2024 ? | |||||
| CYC (ASX) Chart |